Contrasting Moolec Science (MLEC) and The Competition

Moolec Science (NASDAQ:MLEC) is one of 673 publicly-traded companies in the “Holding & other investment offices” industry, but how does it contrast to its competitors? We will compare Moolec Science to related businesses based on the strength of its risk, dividends, institutional ownership, analyst recommendations, earnings, valuation and profitability.

Profitability

This table compares Moolec Science and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Moolec Science	-129.97%	-97.95%	-27.91%
Moolec Science Competitors	-17.66%	-43.09%	-0.30%

Valuation & Earnings

This table compares Moolec Science and its competitors top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Moolec Science	$5.62 million	-$7.31 million	-4.45
Moolec Science Competitors	$1.05 billion	$84.35 million	62.52

Moolec Science’s competitors have higher revenue and earnings than Moolec Science. Moolec Science is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Volatility & Risk

Moolec Science has a beta of -0.54, suggesting that its share price is 154% less volatile than the S&P 500. Comparatively, Moolec Science’s competitors have a beta of 0.03, suggesting that their average share price is 97% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Moolec Science and its competitors, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Moolec Science	0	0	1	0	3.00
Moolec Science Competitors	128	730	961	19	2.47

Moolec Science presently has a consensus price target of $6.00, suggesting a potential upside of 573.70%. As a group, “Holding & other investment offices” companies have a potential upside of 56.91%. Given Moolec Science’s stronger consensus rating and higher probable upside, equities analysts plainly believe Moolec Science is more favorable than its competitors.

Insider and Institutional Ownership

0.1% of Moolec Science shares are held by institutional investors. Comparatively, 54.2% of shares of all “Holding & other investment offices” companies are held by institutional investors. 19.9% of Moolec Science shares are held by insiders. Comparatively, 26.5% of shares of all “Holding & other investment offices” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Moolec Science competitors beat Moolec Science on 9 of the 12 factors compared.

About Moolec Science

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.